Phenomic AI
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Hickory Dr Ste 500, Waltham, Massachu...Website
www.phenomic.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Phenomic AI
Phenomic AI is a biotechnology company focused on developing therapies for solid tumors utilizing an advanced machine learning-powered transcriptomics platform that analyzes single-cell RNA data. The company aims to enhance the understanding of tumor biology and improve patient outcomes by identifying novel druggable targets through its innovative technology. Its primary clients include pharmaceutical companies and research institutions interested in cancer therapies, particularly those targeting stroma-rich cancers. With a team of experienced professionals in oncology, machine learning, and biopharma, Phenomic is committed to bringing groundbreaking new medicines to the clinic.Explore more
Phenomic AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phenomic AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Phenomic AI is spiking on competitors!
Earning: See what the market has to say on Phenomic AI recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Phenomic AI had a recent Job posting/layoffs
Product Launch: Get notified when Phenomic AI launches new products
Congratulate Masked Content for being promoted to Masked Content at Phenomic AI
Funding: Get notified immidiatlly once Phenomic AI has new funding data
Check if Phenomic AI has recently received funding, and reach out quickly before it becomes old news!
Phenomic AI, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Phenomic AI
Compare insights from companies similar to Phenomic AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phenomic AI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phenomic AI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phenomic AI.
Phenomic AI financials insights
Gather financial insights about Phenomic AI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$6M
Phenomic AI Tech Stack
A closer look at the technologies used by Phenomic AI
Phenomic AI News & Media
Phenomic Enters into Strategic Research Collaboration with Astellas for Solid Tumor Cell Therapies
TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--Phenomic AI Inc. (“Phenomic”), a biotech company developing therapies for stroma-rich tumors using its scTx® single cell transcriptomics platform, has entered into a strategic research collaboration with Astellas Pharma Inc., “Astellas” through Xyphos Biosciences, Inc. (a wholly owned subsidiary of Astellas). For this collaboration, Phenomic and Astellas will explore the ability of antibodies, developed by Phenomic and directed at a novel target of thePhenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies
TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--Phenomic AI (“Phenomic”) today announced that they have entered into a strategic collaboration and licensing agreement with Boehringer Ingelheim to discover targets important in stroma-rich cancers. The partners will leverage Phenomic’s expertise in target identification and stromal biology based on its scTx® single-cell transcriptomics platform which will greatly enhance Boehringer’s efforts to develop first-in-class medicines to transform the lives oPhenomic AI Launches with $6 Million Financing and an AI/ML Platform for Targeting the Tumor Stroma
TORONTO & BOSTON--(BUSINESS WIRE)-- #AI--Phenomic AI today announced the official launch of the company with US$6 million seed financing and an AI/ML platform for targeting the tumor stroma.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phenomic AI
Sign Up For FreeTo access detailed company insights
Phenomic AI is a biotechnology company focused on developing therapies for solid tumors utilizing an advanced machine learning-powered transcriptomics platform that analyzes single-cell RNA data. The company aims to enhance the understanding of tumor biology and improve patient outcomes by identifying novel druggable targets through its innovative... Read More
